Vicarious Surgical (RBOT) Common Equity (2020 - 2025)

Vicarious Surgical (RBOT) has reported Common Equity for 6 consecutive years, with $9.8 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Common Equity fell 78.93% year-over-year to $9.8 million in Q4 2025; TTM through Dec 2025 was $9.8 million, a 78.93% decrease from a year earlier, with the FY2025 full-year figure at $9.8 million, down 78.93% from the prior year.
• Common Equity was $9.8 million for Q4 2025 at Vicarious Surgical, down from $14.1 million in the prior quarter.
• Over five years, Common Equity peaked at $129.8 million in Q2 2022 and troughed at -$40.9 million in Q2 2021.
• A 5-year average of $62.7 million and a median of $73.8 million in 2023 frame the typical range for Common Equity.
• Across the five-year window, Common Equity soared 469.16% in 2022 and sank 78.93% in 2025, its largest moves.
• Over 5 years, Common Equity stood at $83.1 million in 2021, then jumped by 33.64% to $111.0 million in 2022, then dropped by 11.78% to $98.0 million in 2023, then sank by 52.33% to $46.7 million in 2024, then slumped by 78.93% to $9.8 million in 2025.
• The last three Common Equity figures came in at $9.8 million (Q4 2025), $14.1 million (Q3 2025), and $23.1 million (Q2 2025), per Business Quant data.